Minghui Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 15
- Advanced biosensing and bioanalysis techniques 8
- RNA modifications and cancer 6
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 15
- Cancer Genomics and Diagnostics 11
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Erwei Song (5 shared papers)Herui Yao (3 shared papers)Duoguang Wu (25 shared papers)Nengtai Ouyang (2 shared papers)Balázs Antus (1 shared paper)Michael S. Exton (1 shared paper)Markus Hörbelt (1 shared paper)Xiaotian He (12 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)PLoS ONE (3 papers)Biosensors and Bioelectronics (2 papers)Gynecologic Oncology (2 papers)Bioinformatics (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Minghui Wang
132 papers receiving 3.8k citations
Minghui Wang's Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 1.1k
- Oncology 897
- Molecular Biology 1.8k
- Immunology 460
- Pulmonary and Respiratory Medicine 487
Countries citing papers authored by Minghui Wang
This map shows the geographic impact of Minghui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghui Wang more than expected).
Fields of papers citing papers by Minghui Wang
This network shows the impact of papers produced by Minghui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghui Wang. The network helps show where Minghui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Minghui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 946 |
| 2 | 2000 | 358 | |
| 3 | 2013 | 140 | |
| 4 | 2013 | 101 | |
| 5 | 2017 | 100 | |
| 6 | 2023 | 94 | |
| 7 | 2019 | 91 | |
| 8 | 2019 | 91 | |
| 9 | 2019 | 68 | |
| 10 | 2020 | 64 | |
| 11 | 2022 | 53 | |
| 12 | 2017 | 51 | |
| 13 | 2011 | 49 | |
| 14 | 2019 | 49 | |
| 15 | 2019 | 49 | |
| 16 | 1997 | 47 | |
| 17 | 2020 | 45 | |
| 18 | LncRNA MEG3-derived miR-361-5p regulate vascular smooth muscle cells proliferation and apoptosis by targeting ABCA1. | 2019 | 44 |
| 19 | 2019 | 43 | |
| 20 | 2022 | 40 |
About Minghui Wang
Minghui Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 137 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (15 papers), Cancer Genomics and Diagnostics (11 papers), Advanced biosensing and bioanalysis techniques (8 papers), Esophageal Cancer Research and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (897 citations), Molecular Biology (1.8k citations), Immunology (460 citations) and Pulmonary and Respiratory Medicine (487 citations). Minghui Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Erwei Song, Herui Yao, Duoguang Wu, Nengtai Ouyang, Balázs Antus, Michael S. Exton, Markus Hörbelt, Xiaotian He, Fei Chen and Dan Liao. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Biosensors and Bioelectronics, Gynecologic Oncology and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.